(Q35967329)

11 August 2017

1 reference

title

Chemotherapeutic options in the management of anal cancer (English)

1 reference

11 August 2017

1 reference

Pascal Gervaz

1

1 reference

11 August 2017

Abdelkarim S Allal

series ordinal

2

1 reference

11 August 2017

Arnaud Roth

series ordinal

3

1 reference

11 August 2017

Philippe Morel

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Expert Opinion on Pharmacotherapy

11 August 2017

published in

1 reference

11 August 2017

volume

5

1 reference

11 August 2017

issue

12

1 reference

11 August 2017

page(s)

2479-2484

1 reference

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

Carcinoma of the anal canal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

Anal carcinoma: histology, staging, epidemiology, treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

Combined therapy for cancer of the anal canal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

Outcome analysis of HIV-positive patients with anal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

The efficacy of chemoradiation therapy in HIV seropositive patients with squamous cell carcinoma of the anus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2479

10.1517/14656566.5.12.2479

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference